The impact of CD56 expression in smoldering myeloma patients on early progression

Hematol Oncol. 2023 Aug;41(3):587-589. doi: 10.1002/hon.3104. Epub 2022 Dec 1.

Authors

Laura Notarfranchi^{1

2}, Roberta Segreto², Rosanna Vescovini¹, Anna Benedetta Dalla Palma², Valentina Marchica¹, Jessica Burroughs-Garcia¹, Denise Toscani¹, Giannalisa Todaro², Vincenzo Raimondi¹, Nicolas Thomas Iannozzi¹, Sabrina Bonomini², Gabriella Sammarelli², Luisa Craviotto^{1

2}, Mario Pedrazzoni¹, Paola Storti¹, Nicola Giuliani^{1

2}

Affiliations

¹ Department of Medicine and Surgery, University of Parma, Parma, Italy.
² Hematology Unit, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.

PMID: 36441875
DOI: 10.1002/hon.3104

No abstract available

Keywords: CD56; flow cytometry; smoldering myeloma.

Publication types

Letter

MeSH terms

Bone Marrow
Disease Progression
Humans
Multiple Myeloma*
Smoldering Multiple Myeloma*

Grants and funding